Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
670
datasets available to search
ShareScore release 0.9.0
Dataset results
670 results for “review study”
The influence of a priori grouping on inference of genetic clusters: simulation study and literature review of the DAPC method
Open the record for dataset details and reuse information.
Data from: Characteristics of patients included and enrolled in studies on the prognostic value of serum biomarkers for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review
Open the record for dataset details and reuse information.
A critical review of uterine leiomyoma with subsequent recurrence or metastasis: A multicenter study of 62 cases
Open the record for dataset details and reuse information.
Data from: Is there a causal link between knee loading and knee osteoarthritis progression? A systematic review and meta-analysis of cohort studies and randomised trials
Open the record for dataset details and reuse information.
A review of response rates over time in registry-based studies using patient-reported outcome measures
Open the record for dataset details and reuse information.
Data from: Outcomes of systolic heart failure patients presenting with sepsis to the emergency department of a tertiary hospital: a retrospective chart review study from Lebanon
Open the record for dataset details and reuse information.
Data from: Financial conflicts of interest of clinicians making submissions to the panCanadian Oncology Drug Review: a descriptive study
Open the record for dataset details and reuse information.
LBA-ECO ND-06 Land Use Effects on Soil Nutrients: A Review of Studies 1950-2001
This data set provides measurements of soil properties compiled from 39 studies on nutrient dynamics in natural forests and forest-derived land uses (pasture, shifting cultivation and tree plantations) conducted in Amazonia over the period of 1950-2001. The initial literature survey for the data consisted of more than 100 studies conducted during this period.The objectives of this project were to compare soil data from major land uses across Amazonia and identify gaps in present knowledge that offer direction for future research. Five widely cited hypotheses were tested concerning the effects of land-use change on soil properties by analyzing data compiled from 39 studies in multi-factorial ANOVA models:?¢ effective cation exchange capacity (ECEC), and exchangeable calcium (Ca) concentrations rise and remain elevated following the slash-and-burn conversion of forest to pasture or crop fields¢ soil contents of total carbon (C), nitrogen (N), and inorganic readily (i.e., Bray, Mehlich I or resin) extractable phosphorus (Pi) decline following forest-to-pasture conversion?¢ soil concentrations of total C, N, and Pi increase in secondary forests with time since abandonment from agricultural activities?¢ soil nutrient conditions under all tree-dominated land-use systems (natural or not) remain the same?¢ higher efficiencies of nutrient utilization occur where soil nutrient pools are lower There is one comma-delimited ASCII file (.csv) with this data set and a list of the 39 studies used in this data set provided as a companion file in text format.
Data from: Comparison of methodological quality of positive versus negative comparative studies published in Indian medical journals: a systematic review
Objectives: Published negative studies should have the same rigour of methodological quality as studies with positive findings. However, the methodological quality of negative versus positive studies is not known. The objective was to assess the reported methodological quality of positive versus negative studies published in Indian medical journals. Design: A systematic review (SR) was performed of all comparative studies published in Indian medical journals with a clinical science focus and impact factor >1 between 2011 and 2013. The methodological quality of randomised controlled trials (RCTs) was assessed using the Cochrane risk of bias tool, and the Newcastle-Ottawa scale for observational studies. The results were considered positive if the primary outcome was statistically significant and negative otherwise. When the primary outcome was not specified, we used data on the first outcome reported in the history followed by the results section. Differences in various methodological quality domains between positive versus negative studies were assessed by Fisher's exact test. Results: Seven journals with 259 comparative studies were included in this SR. 24% (63/259) were RCTs, 24% (63/259) cohort studies, and 49% (128/259) case–control studies. 53% (137/259) of studies explicitly reported the primary outcome. Five studies did not report sufficient data to enable us to determine if results were positive or negative. Statistical significance was determined by p value in 78.3% (199/254), CI in 2.8% (7/254), both p value and CI in 11.8% (30/254), and only descriptive in 6.3% (16/254) of studies. The overall methodological quality was poor and no statistically significant differences between reporting of methodological quality were detected between studies with positive versus negative findings. Conclusions: There was no difference in the reported methodological quality of positive versus negative studies. However, the uneven reporting of positive versus negative studies (72% vs 28%) indicates a publication bias in Indian medical journals with an impact factor of >1.
Data from: Health Canada's use of accelerated review pathways and therapeutic innovation, 1995-2016: a cohort study
Objectives: This study examines the use of accelerated approval pathways by Health Canada over the period 1995 to 2016 inclusive and the relationship between the use of these pathways and the therapeutic gain offered by new products. Design: Cohort study. Data sources: Therapeutic Products Directorate, Biologics and Genetic Therapies Directorate, Notice of Compliance database, Notice of Compliance with conditions web site, Patented Medicine Prices Review Board, La revue Prescrire, World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system. Interventions: None. Primary and secondary outcomes: Percent of new drugs evaluated by Health Canada that went through an accelerated pathway between 1995 and 2016 inclusive. Kappa values comparing the review status to assessments of therapeutic value for individual drugs. Results: 438 (70.3%) drugs went through the standard pathway, 185 (29.7%) an accelerated pathway. Therapeutic evaluations were available for 509 drugs. Health Canada used an accelerated approval pathway for 159 of the 509 drugs whereas only 55 were judged to be therapeutically innovative. The Kappa value for the entire period for all 509 drugs was 0.276 (95% CI 0.194, 0.359) or fair. Conclusion: Health Canada's use of accelerated approvals was stable over the entire time period. Its ability to predict which drugs will offer a major therapeutic gain is relatively poor. The findings in this study should provoke a discussion about whether Health Canada should continue to use these pathways and if so how their use can be improved.
Dataset for An Empirical Study of Static Analysis Tools for Secure Code Review
Open the record for dataset details and reuse information.
Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3)
ClinicalTrials.gov study NCT04362163. IPD Sharing: NO. Countries: 1. Publications: 0.
Integrative Korean Medicine Treatment for Pediatrics After Traffic Accident: Retrospective Chart Review Study and Survey
ClinicalTrials.gov study NCT06410586. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of the Use of Jigsaw Technique on Nursing Students' Critical Article Reviews and Students' Opinions on the Technique- Quasi-Experimental Study
ClinicalTrials.gov study NCT06339502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Transcranial Direct Current Stimulation (tDCS) in Young Individuals with Major Depressive Disorder: a Literature Review and Feasibility Study
ClinicalTrials.gov study NCT06518642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
ClinicalTrials.gov study NCT06354777. IPD Sharing: NO. Countries: 1. Publications: 0.
This Study Was a Prospective, One-arm Open Phase II Clinical Trial. A Systematic Review of the pCR of Apatinib in Combination With the Albumin Paclitaxel and Carboplatin Regimens for the Neoadjuvant T
ClinicalTrials.gov study NCT03650738. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
ClinicalTrials.gov study NCT06728319. IPD Sharing: NO. Countries: 1. Publications: 0.
A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease
ClinicalTrials.gov study NCT02608515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of the SPaRK (Supportive and Palliative Care Review Kit) Model of Care for Advanced Cancer Patients Who Have an Unplanned Admission to Singapore General Hospital
ClinicalTrials.gov study NCT02559336. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.